Literature DB >> 21284612

Hemicrania continua changed to chronic paroxysmal hemicrania after treatment with cyclooxygenase-2 inhibitor.

Kai Ivar Müller1, Svein Ivar Bekkelund.   

Abstract

Remission of hemicrania continua (HC) and transformation from HC to chronic paroxysmal hemicrania (CPH) are unusual. We report a patient with left-sided HC who, after a period of remission, presented as CPH. The continuous HC headache disappeared completely after initiating treatment with cyclooxygenase (COX)-2 inhibitor, but reappeared on the same side after 14 months remission with paroxysmal, frequent, intense and short-lasting headache attacks accompanied by ipsilateral cranial autonomic symptoms. This happened shortly after the treatment was discontinued because of withdrawal of the COX-2 inhibitor from the market. The response to indomethacin was prompt, and the patient became completely free from her paroxysmal headache with a dose of 50 mg 2 times daily. This case questions a possible modification effect on the course of HC by use of COX-2 inhibitor, as well as further supporting that some aspects of the pathophysiology of HC may resemble those of CPH, and may argue for common biological mechanisms in HC and CPH.
© 2011 American Headache Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21284612     DOI: 10.1111/j.1526-4610.2010.01820.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  6 in total

Review 1.  Interictal pain in primary headache syndromes.

Authors:  Michael J Marmura; William B Young
Journal:  Curr Pain Headache Rep       Date:  2012-04

Review 2.  When indomethacin fails: additional treatment options for "indomethacin responsive headaches".

Authors:  Shuhan Zhu; Brian McGeeney
Journal:  Curr Pain Headache Rep       Date:  2015-03

Review 3.  Trigeminal autonomic cephalalgias: beyond the conventional treatments.

Authors:  Sarah Miller; Manjit Matharu
Journal:  Curr Pain Headache Rep       Date:  2014

Review 4.  Therapeutical approaches to paroxysmal hemicrania, hemicrania continua and short lasting unilateral neuralgiform headache attacks: a critical appraisal.

Authors:  Carlo Baraldi; Lanfranco Pellesi; Simona Guerzoni; Maria Michela Cainazzo; Luigi Alberto Pini
Journal:  J Headache Pain       Date:  2017-07-20       Impact factor: 7.277

Review 5.  Hemicrania continua: clinical review, diagnosis and management.

Authors:  Sanjay Prakash; Payal Patel
Journal:  J Pain Res       Date:  2017-06-29       Impact factor: 3.133

6.  Headache patients' satisfaction with telemedicine: a 12-month follow-up randomized non-inferiority trial.

Authors:  K I Müller; K B Alstadhaug; S I Bekkelund
Journal:  Eur J Neurol       Date:  2017-04-21       Impact factor: 6.089

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.